Abstract: The use of a tag moiety comprising a biotinylation domain, such as biotin carboxyl carrier protein (BCCP), as a protein folding marker and protein solubility enhancer in the orientated surface capture of products of heterologously expressed genes is described. Methods for increasing the solubility of proteins and determining the folded state of a protein are also disclosed. The uses and methods of the invention can be carried out in a multiplexed manner on more than one protein in the formation of libraries. In addition the nucleic acid molecule encoding the biotinylation domain of the tag moiety can be used to increase the proportion of clones in a library that express the protein of interest.

Abstract: Example network management systems and methods are described. In one implementation, a method identifies at least one network resource to be managed and identifies at least one domain to be managed. The method further identifies at least one service provider to be managed. A fusion object is created that defines the network resource, the domain, and the service provider to be managed.

Abstract: Substituted cinnamoyl anthranilate compounds exhibiting anti-fibrotic activity; or derivatives thereof, analogues thereof, pharmaceutically acceptable salts thereof, and metabolites thereof, with the proviso that the compound is no Tranilast.

Abstract: Aspects of the present disclosure involve systems, methods, computer program products, and the like, for implementing providing a web conferencing service. In one example, the system and methods involve a real-time application programming interface (RTAPI) component in the telecommunications network. The RTAPI is configured, in one embodiment, to provide a platform through which one or more users of the telecommunications network interfaces with one or more conferencing components of the network. In one example, the RTAPI may be configured to coordinate a dial-out to a participant of a conference at a designated time such that the participant is entered into the conference automatically.

Abstract: An optical fiber connector plug having an anti-snag guide to prevent the plug from being caught on corners and edges when an attached cable is being pulled around corners and edges during installation and removal of the optical fiber connector plug. The optical fiber connector plug includes a unique arrangement of different width apertures corresponding to a removal tool having corresponding different width prongs to be received by the apertures to release the optical fiber connector plug from a coupling adapter.

Abstract: The present invention relates to oxime ether-, hydrazone- or azomethine-substituted phenylamidines of the general formula (I), to a process for their preparation, to the use of the amidines according to the invention for controlling unwanted microorganisms and also to a composition for this purpose, comprising the amidines according to the invention. Furthermore, the invention relates to a method for controlling unwanted microorganisms by applying the compounds according to the invention to the microorganisms and/or their habitat.

Abstract: Substituted cinnamoyl anthranilate compounds exhibiting anti-fibrotic activity; or derivatives thereof, analogues thereof, pharmaceutically acceptable salts thereof, and metabolites thereof; with the proviso that the compound is not Tranilast.

Abstract: The present invention relates to methods of screening for expression of a soluble candidate protein within an expression library of candidate proteins. The method involves fusing each candidate protein in the library to a peptide substrate and identifying cells that express soluble candidate protein by detecting enzymatic modification of the peptide substrate.

Abstract: The present invention relates to 4-cycloalkyl- or 4-aryl-substituted phenoxyphenylamidines of the general formula (I), to a process for their preparation, to the use of the amidines according to the invention for controlling unwanted microorganisms and also to a composition for this purpose, comprising the phenoxyphenylamidines according to the invention. Furthermore, the invention relates to a method for controlling unwanted microorganisms by applying the compounds according to the invention to the microorganisms and/or their habitat.

Abstract: An instrumented orthopaedic implant, such as an intramedullary (IM) nail, is disclosed. The implant has the capacity to provide an accurate measurement of the applied mechanical load across the implant. The implant includes sensors and associated electronic components located in recesses on the outer surface of the implant. The implant houses the sensing apparatus, the interface circuitry, the data transmitter, and the power receiver. The hermetically sealed housing is adapted for implantation in the body of a patient. The implant is used with a controller which communicates with it by telemetry, and there is an acting unit connected to the electronic components which is adapted to carry out a function based upon a condition detected by the sensors.

Abstract: A load-bearing medical implant is disclosed that includes a load-bearing structure with a cavity extending into the outer surface of the structure. The cavity accommodates a sensor that is held in a fixed position within the cavity by an encapsulant. The cavity is covered by a plate that is welded over the cavity in close proximity to the sensor and encapsulant to provide a seal over the cavity and the electronic component without causing thermal damage to the encapsulant or sensor despite the close proximity of the encapsulant and sensor to the welded areas of the plate and structure. Methods for encapsulating the sensor in the cavity, methods for encapsulating a wire bus leading from the sensor through a channel in the implant and methods for pulsed laser welding of weld plate over the sensor and encapsulant with thermal damage to either are disclosed.

Abstract: The invention relates generally to orthopaedic implants, and more particularly to orthopaedic implants having data acquisition capabilities and their use in monitoring and diagnosing fracture healing. RSA is also disclosed as a method for measuring inter-fragmentary movement in long bone fractures in order to confirm whether the fracture is reduced and for detecting changes in stiffness of the healing callus.

Abstract: Concepts and technologies are described herein for an abstract relational model for transforming data into consumable content. In accordance with the concepts and technologies disclosed herein, a computing device can execute a transformation engine for transforming data into the consumable content. The computing device can be configured to generate an abstract relational model from data to analyze the data and to identify relationships within data elements or other portions of the data. The computing device also can determine a visualization model to apply to the data and to choose a world based upon the determined visualization model. The computing device can obtain rules associated with the selected or chosen world, and can apply the rules to the data to generate the output. In some embodiments, the computing device can be configured to obtain and apply feedback to the output.

Abstract: The present invention relates to halogenated compounds of formula (I) with the substituents as described within the specification. The compounds may be useful as anti-fibrotic agents. The present invention also relates to methods for their preparation.

Abstract: The present invention relates to arylcarbonyl and heteroarylcarbonyl anthranilate compounds that may be useful as anti-fibrotic agents. The present invention also relates to methods for their preparation, pharmaceutical compositions containing these compounds and uses of these compounds in the treatment disorders.

Abstract: Methods for treating eye diseases associated with inflammation and/or vascular proliferation in subjects are disclosed. The methods include administering therapeutically effective amounts of a tranilast compound, in particular (E)-2-[[3-(3-Methoxy-4-propargyloxy)phenyl)-1-oxo-2-propenyl]amino]benzoic acid or (E)-2-[[3,4-Bis(difluoromethoxy)phenyl)-1-oxo-2-propenyl]amino]benzoic acid or pharmaceutically acceptable salts or solvates thereof.

Abstract: A telemetric system includes a telemetric implant, a reader unit adapted to read signals from the telemetric implant, and an antenna adapted for connection to the reader unit and to receive signals from the telemetric implant. The antenna has a first coil, a second coil, and a connector. The first coil is electrically connected to the second coil, and the connector allows for movement of the first and second coils relative to each other. The antenna may be used to send radio-frequency power to the telemetric implant and receives data from the telemetric implant.

Abstract: The present invention relates to phenoxyphenylamidines of the general formula (I), to a process for their preparation, to the use of the amidines according to the invention for controlling unwanted microorganisms and also to a composition for this purpose, comprising the phenoxyphenylamidines according to the invention. Furthermore, the invention relates to a method for controlling unwanted microorganisms by applying the compounds according to the invention to the microorganisms and/or their habitat.

Abstract: An instrumented orthopaedic implant, such as an intramedullary (IM) nail, is disclosed. The implant has the capacity to provide an accurate measurement of the applied mechanical load across the implant. The implant includes sensors and associated electronic components located in recesses on the outer surface of the implant. The implant houses the sensing apparatus, the interface circuitry, the data transmitter, and the power receiver. The hermetically sealed housing is adapted for implantation in the body of a patient. The implant is used with a controller which communicates with it by telemetry, and there is an acting unit connected to the electronic components which is adapted to carry out a function based upon a condition detected by the sensors.